Targeting Mitochondria 2025 Speakers & Sessions
Day 1 - Wednesday October 22, 2025
Workshops
Workshop 1: How to Evaluate Mitochondria Function?
Naïg Gueguen, Mitovasc Institute, Centre Hospitalier Universitaire d'Angers, France
Workshop 2: Mitochondria Transplantation: From Theoretical to Clinical Applications
Andrés Caicedo, Universidad San Francisco de Quito, Ecuador
Day 2 - Thursday, October 23, 2025
Congress Sessions
Targeting Mitochondria 2025 Keynote Speech
• Nick Lane – Mitochondria and the Meaning of Life
Session 1: Mitochondrial Dynamics in Health and Diseases: Mechanistic and Perspectives
• Marc Germain – Actin Dynamics In Mitochondrial Function: Implications For Cellular Homeostasis And Disease
• Yosuke Togashi – Immune Evasion through Tumor-Derived Mitochondrial Transfer
• Edmund Kunji – Targeting Mitochondrial Pyruvate Carrier: Impact on Future Metabolic Therapies
• Luca Gattinoni – Fighting Fire with Fire: Boosting T Cell Therapy by Intercellular Mitochondrial Transfer
• Joanna Rorbach – Mitochondrial Protein Synthesis: A Key on Health and Disease / Mitoribosomes and Disease
• Tatjana Kleele – Mitochondrial Dynamics: Steering the Future of Mitochondrial Remodeling in Health and Disease
• Florent Waltz – How Mitochondria Organize Their Powerhouse Machinery for Optimal Performance
Short Oral Presentations
Quantitative Cellular Characterization of Extracellular Mitochondria Uptake and Delivery
Gregory Lavieu, INSERM, Université Paris Cité, France
The Mitochondrial DNAJC Co-Chaperone TCAIM Reduces A-Ketoglutarate Dehydrogenase Protein Levels to Regulate Metabolism Wen Yang, Shanghai Jiaotong University, China
Can We Untie the Linkage Between Life Extension and a Decline in Healthspan via Healthy Mithophagy
Einav Gross, Hebrew University of Jerusalem, Israel
Mitochondrial Respiration Atlas Reveals Differential Changes in Mitochondrial Function Across Sex and Age
Fangluo Chen, Johns Hopkins University, United States of America
Session 2: Advances in Mitochondria: Insights, Debates, and Controversies
• Alessandro M. Morelli – Delocalisation of the Macromolecular Devices for Efficient ATP Synthesis in Extra-Mitochondrial Districts
Short Oral Presentations
Regulation of Respiratory Supercomplexes Through Inhibitory Cytochrome C Oxidase Y304 Phosphorylation Causes Mitochondrial Dysfunction in Diabetic Heart
Tasnim Arroum, Wayne State University, United States of America
Time-Restricted Feeding, Whole-Body Mitochondrial Synchronization and Health Status
Dylan Sarver, University of California Los Angeles, United States of America
Day 3 - Friday, October 24, 2025
Congress Sessions
Targeting Mitochondria 2025 Keynote Speech
• Adam Szewczyk – Targeting Mitochondrial Channels: Update and Strategies
Session 3: Emerging Trends and Innovations in Mitochondria Research
• Alessandro Prigione – Brain Organoids for Drug Discovery of Mitochondrial Neurological Disorders
• David Rizo Roca – Mitochondria and Creatine: Perspectives and Strategies
• Alberto Anel – Mitochondrial Cybrids: Advancing Precision Oncology
• Ayumu Sugiura – The Role of Mitochondrial-Derived Vesicles in Peroxisome Biogenesis
Session 4: Mitochondria medicine: Strategies to Target Mitochondria, Clinical Trials and Potential Mitochondria-Based Therapies
• Volkmar Weissig – Drug Development for the Therapy of Mitochondrial Diseases
• Kosuke Kusamori – Development of Mitochondria-Based Therapeutic Strategies for Disease Treatment
• Gökhan Burçin Kubat – Mitochondrial Transplantation: From Skeletal Muscle Atrophy to Human Clinical Advances and Perspectives
• Andrés Caicedo - Mitochondria Transplantation: From Theoretical to Clinical Applications
Short Oral Presentations and Innovations
MNRR1-dervied peptides, a promising therapeutic target for mitochondrial dysfunction syndromes
Lawrence Grossman, Wayne State University, USA
Advanced Strategies for Correcting Mitochondrial Mutations in Human Disease Models
Martijn Koppens, UMC Utrecht, Netherlands
Restoring Mitochondrial Quantity and Quality to Reverse Warburg Effect and Drive Tumor Differentiation
Jiangbin Ye, Stanford University, United States of America
Mitochondrial Transplantation as a Novel Therapeutic Strategy for Anthracycline-Induced Cardiotoxicity
Sofia Trigo Anca, Centro Nacional de Investigaciones Cardiovasculares, Spain
Targeting Mitochondria 2025 Awards
WMS Concluding Remarks
